Oncimmune
Founded in 2006, Oncimmune specializes in early cancer detection using proprietary autoantibody assay technologies. Headquartered in Nottingham, England, with a CLIA-certified lab in Kansas City, the company aims to detect over 90% of solid-tumor cancers through its tests for lung, breast, colorectal, prostate, stomach, pancreatic, and ovarian cancers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.